Stop spoon dosing

You grab for the cough syrup for some relief from that nasty lingering cold, what do you measure the dose with? Many of us use teaspoons or table spoons to measure out doses for ourselves and our children but this results in dosage errors. This new study finds that errors in estimating doses can be mitigated by changing the serving measurements on the dosage facts panel from teaspoons to milliliters.

A previous study by authors Koert van Ittersum, PhD at the University of Groningen (The Netherlands) and Brian Wansink, PhD of Cornell University found that when individuals use teaspoons to measure medicine they tend to under-serve by 8.4% and when using table spoons they over-serve by 11.6%.

For this study, Van Ittersum and Wansink proposed that by writing the Drug Facts and dosage information in milliliters, which are more difficult to estimate visually, people would choose more accurate measuring devices to measure out doses and would be less likely to make dosage errors. Of the 177 young adults that participated in this study, 34.5% reported using kitchen spoons most frequently to measure medicine. The researchers found that when these study participants were given dosage information in teaspoons 60.9% chose a teaspoon to measure with while none of them chose the milliliter measuring cup. However, when the dosage recommendation was given in milliliters the teaspoon and the measuring cup were equally popular among this group. These results indicate that the risk of dosage error decreases by around 50% by simply changing the recommended units of measurement from tea spoons to milliliters.

"When measuring medicine for ourselves or our children, we often use regular kitchen spoons but they are not accurate measuring instruments," explains lead author Koert van Ittersum, "While we feel that we can estimate teaspoon doses, milliliters are much harder to estimate visually, therefore people are more likely to use accurate measuring spoons or cups when given dosage information in milliliters."

In conclusion, the authors recommend that the US Food and Drug Administration mandates that the pharmaceutical industry not use teaspoons on Drug Facts and dosing information. They also emphasize the importance of not spoon-dosing at home, instead using the measuring cups that typically come with liquid medicine.

Most Popular Now

Therapy using dual immune system cells effectively…

A newly developed immunotherapy that simultaneously uses modified immune-fighting cells to home in on and attack two antigens, or foreign substances, on cancer cells was ...

How to develop new drugs based on merged datasets

Polymorphs are molecules that have different molecular packing arrangements despite identical chemical compositions. In a recent paper, researchers at GlaxoSmithKline (GS...

New drug combination effective against SARS-CoV-2 …

More countries with greater resources are opening up for a more normal life. But COVID-19 and the SARS-CoV-2 virus are still a significant threat in large parts of the wo...

Cleveland Clinic study suggests steroid nasal spra…

A recent Cleveland Clinic study found that patients who regularly use steroid nasal sprays are less likely to develop severe COVID-19-related disease, including a 20 to 2...

Sanofi to focus its COVID-19 development efforts o…

Recent positive interim results of Sanofi's mRNA-based COVID-19 vaccine candidate Phase 1/2 study confirm the company's platform robust capabilities and strategy in mRNA...

Discovery of mechanics of drug targets for COVID-1…

A team of international researchers, including McGill Professor Stéphane Laporte, have discovered the working mechanism of potential drug targets for various diseases suc...

Phase II/III trial shows Ronapreve™ (casirivimab a…

Roche (SIX: RO, ROG; OTCQX: RHHBY) today confirmed positive data from the phase II/III 2066 study, investigating Ronapreve™ (casirivimab and imdevimab) in patients hospit...

Pfizer and BioNTech receive first U.S. FDA Emergen…

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced that the U.S. Food and Drug Administration (FDA) has authorized for emergency use a booster dose of the P...

AZD7442 request for Emergency Use Authorization fo…

AstraZeneca has submitted a request to the US Food and Drug Administration (FDA) for an Emergency Use Authorization (EUA) for AZD7442, its long-acting antibody (LAAB) com...

Pfizer and BioNTech receive CHMP positive opinion …

Pfizer Inc. (NYSE: PFE, "Pfizer") and BioNTech SE (Nasdaq: BNTX, "BioNTech") today announced that the Committee for Medicinal Products for Human Use (CHMP) of the Europea...

Boehringer Ingelheim acquires Abexxa Biologics to …

Boehringer Ingelheim announced the acquisition of Abexxa Biologics Inc., a biopharmaceutical company taking a new approach in the fields of immuno-oncology and oncology r...

GSK welcomes WHO recommendation for broad roll-out…

GlaxoSmithKline (GSK) plc welcomes and applauds the WHO recommendation for the broader deployment of GSK's RTS,S malaria vaccine to reduce childhood illness and deaths fr...